AGP Limited (PSX: AGP)

Market Cap	49.66B
Revenue (ttm)	23.45B
Net Income (ttm)	2.06B
Shares Out	280.00M
EPS (ttm)	7.38
PE Ratio	24.02
Forward PE	14.69
Dividend	2.50 (1.35%)
Ex-Dividend Date	Mar 8, 2024

Volume	330,393
Average Volume	486,547
Open	186.00
Previous Close	185.34
Day's Range	183.50 - 186.90
52-Week Range	60.21 - 194.89
Beta	0.52
RSI	61.91
Earnings Date	Feb 14, 2025

About AGP Limited

AGP Limited manufactures, sells, wholesales, distributes, exports, imports, markets, deals in pharmaceutical and healthcare products under licensing arrangements in Pakistan. The company offers products in the areas of aminoglycosides, angiotensin II antagonist, anti epileptics, anti-gout, anti-infective antidiarrheal, anti-inflammatory enzyme, antidiarrheal microorganisms, antifibrinolytic, antihistamines systemic, antileuk anti-ashtm sys, antineoplastic agent, anti-obesity, antirheumatic non-steroid, antispasmodic and anticholinergic plain, a...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1989
• Employees: 1,574
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: AGP

Financial Performance

In 2023, AGP Limited's revenue was 18.74 billion, an increase of 29.63% compared to the previous year's 14.46 billion. Earnings were 1.57 billion, a decrease of -0.31%.